The technology described herein relates generally to medical lasers and, more particularly, to surgical applications of medical lasers.
Surgical instruments typically employed in applications such as orthopedics and oral surgery, in the ablation or cutting of hard tissue or bone, include high speed oscillating saws, manual saws or chisels. For example, depicted in
In accordance with the teachings provided herein, a surgical handpiece for providing an electromagnetic cutting blade is disclosed. The handpiece, comprises a body portion having an input end and an output end, a plurality of optical fibers for receiving laser energy having a wavelength within a predetermined wavelength range, wherein the optical fibers are received in the body portion at the input end and extend to the output end, and an optical fiber transition region within the body portion for arranging the plurality of optical fibers into a predetermine cutting shape at the output end, wherein laser energy transmitted from the arranged optical fibers at the output end react with fluid molecules near the surgical target to generate micro-explosions that result in a cutting effect.
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
Depicted in
The laser energy 102 interacts with fluid particles 106 in the interaction zone and with water molecules contained within the biological target. The laser energy is absorbed by and excites the fluid particles 106 and the water molecules resulting in sequential micro-explosions of the fluid particle and water molecules. These micro-explosions generate mechanical disruptive forces. The disruptive forces when applied to the biological target result in a cutting effect on the surface of the target.
The laser energy 102 is at a wavelength and energy level sufficient to excite micro-explosions in water molecules but not at levels sufficient to damage biological tissue. In the example system, typical values for total laser energy (energy emitted by all fibers) per laser pulse may range from about 0.05 J to about 2.0 J, and the energy may be generated with a wavelength ranging from about 2.75 μm to about 3.00 μm.
The fluid particles injected into the interaction zone perform a number of purposes. Some of the fluid particles absorb beams of light, explode, and impart a mechanical disruptive force to the target. Remaining portions of the fluid particles reduce the temperature surrounding the explosion so that living cells adjacent the target area will not be exposed to the extreme heat resulting in cell necrosis and death.
Very efficient tissue cutting without adjacent cells necrosis can be achieved using this technology. In the example system, individual beams are arranged parallel to each other in the same plane creating a linear segment of beams at a target that are sequential fired. This reduces the likelihood of a manual sweeping action being used to cut through tissue resulting in an efficient and accurately sized cut.
The handpiece 100 is coupled to an electromagnetic energy source 108 (i.e., laser energy source) which generates laser energy. The electromagnetic energy source 108 may include devices comprising mirrors, lenses, and other optical components for collimating and focusing generated laser energy. The generated laser energy is delivered to the handpiece 100 via a plurality of optical fibers 110 which extend into the interior of the handpiece 100.
The electromagnetic energy source 108 may include a variety of different lasers or other sources of light. The electromagnetic energy source 108 may use an erbium, chromium, yttrium, scandium, gallium garnet (Er, Cr:YSGG) solid state laser, which generates light having a wavelength in a range of approximately 2.70 to 2.80 μm. Laser systems used in other examples include an erbium, yttrium, aluminum garnet (Er:YAG) solid state laser, which generates radiation having a wavelength of 2.94 μm; a chromium, thulium, erbium, yttrium, aluminum garnet (CTE:YAG) solid state laser, which generates radiation having a wavelength of 2.69 μm; an erbium, yttrium orthoaluminate (Er:YAL03) solid state laser, which generates radiation having a wavelength in a range of approximately 2.71 to 2.86 μm; a holmium, yttrium, aluminum garnet (Ho:YAG) solid state laser, which generates radiation having a wavelength of 2.10 μm; a quadrupled neodymium, yttrium, aluminum garnet (quadrupled Nd:YAG) solid state laser, which generates radiation having a wavelength of 266 nm; excimer lasers, which generates radiation having a wavelength of 193-308 nm; a carbon dioxide (C02) laser, which generates radiation having a wavelength in a range of approximately 9.0 to 10.6 μm; and semiconductor diode lasers, which generate radiation having a wavelength in a range of approximately 400 to 1550 nm.
Depicted in
Depicted in
Other physical configurations of the laser handpiece device can be constructed. Depicted in
Depicted in
Depicted in
The laser handpiece may be constructed with venous numbers of fibers, fiber dimensions and shapes. For example, the handpiece may comprise about 10 fibers for emitting 10 laser beams for cutting a 1 cm bone. As another example, about 50 fibers for emitting 50 beams may be employed for the cutting of a 5 cm bone.
The light in the fibers are collimated and concentrated to produce a very concentrated light in each optical fiber. Depicted in
Depicted in
As illustrated in
Depicted in
Depicted in
Depicted in
This written description uses examples to disclose the invention, including the best mode, and also to enable a person skilled in the art to make and use the invention. The patentable scope of the invention may include other examples.
It should be understood that as used in the description herein and throughout the claims that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein and throughout the claims that follow, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise. Further, as used in the description herein and throughout the claims that follow, the meaning of “each” does not require “each and every” unless the context clearly dictates otherwise. Finally, as used in the description herein and throughout the claims that follow, the meanings of “and” and “or” include both the conjunctive and disjunctive and may be used interchangeably unless the context expressly dictates otherwise; the phrase “exclusive of’ may be used to indicate situations where only the disjunctive meaning may apply.
This application is a continuation application and claims the benefit, and priority benefit, of U.S. patent application Ser. No. 13/633,967, filed Oct. 3, 2012, which claims the benefit and priority benefit of U.S. Provisional Application No. 61/542,712, filed Oct. 3, 2011, the entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4653495 | Nanaumi | Mar 1987 | A |
4686979 | Gruen et al. | Aug 1987 | A |
5071422 | Watson et al. | Dec 1991 | A |
5250045 | Bohley | Oct 1993 | A |
5395361 | Fox et al. | Mar 1995 | A |
6106516 | Massengill | Aug 2000 | A |
6162052 | Kokubu | Dec 2000 | A |
6203537 | Adrian | Mar 2001 | B1 |
6464694 | Massengill | Oct 2002 | B1 |
6724958 | German et al. | Apr 2004 | B1 |
9956039 | Boutoussov | May 2018 | B2 |
20050080404 | Jones et al. | Apr 2005 | A1 |
20050281887 | Rizoiu et al. | Dec 2005 | A1 |
20060189965 | Litvak et al. | Aug 2006 | A1 |
20080058783 | Altshuler et al. | Mar 2008 | A1 |
20080287941 | Jones et al. | Nov 2008 | A1 |
20120015319 | Jones et al. | Jan 2012 | A1 |
20130085486 | Boutoussov | Apr 2013 | A1 |
20130310819 | Neuberger | Nov 2013 | A1 |
Number | Date | Country |
---|---|---|
102005057617 | Jun 2007 | DE |
2763618 | Aug 2014 | EP |
60-148566 | Aug 1985 | JP |
10-211211 | Aug 1998 | JP |
11-511386 | Oct 1999 | JP |
2003-135483 | May 2003 | JP |
2014-528804 | Oct 2014 | JP |
9707928 | Mar 1997 | WO |
9922656 | May 1999 | WO |
2013052531 | Apr 2013 | WO |
Entry |
---|
United States Patent and Trademark Office; PCT International Search Report, Issued in Connection to PCT/US12/58536; dated Jan. 10, 2013; 3 pages; US. |
United States Patent and Trademark Office; PCT Written Opinion of the International Searching Authority Issued in Connection to PCT/US12/58536; dated Jan. 10, 2013; 7 pages; US. |
Canadian Intellectual Property Office; Issued in Connection to CA2850495; Apr. 21, 2015; 4 pages; Canada. |
Japanese Patent Office, Notification of Reason for Rejection, Issued in Connection to JP2014-534649; dated Feb. 12, 2015; 6 pages; Japan. |
European Patent Office; Extended European Search Report, Issued in Connection to EP12839133.1; dated May 22, 2015; 6 pages; Europe. |
European Patent Office; Communication Pursuant to Article 94(3) EPC, Issued in Connection to EP12839133.1; dated Oct. 21, 2016; 3 pages; Europe. |
European Patent Office; Communication Pursuant to Article 94(3) EPC, Issued in Connection to EP12839133.1; dated Jun. 27, 2017; 4 pages; Europe. |
European Patent Office; Communication Pursuant to Article 94(3) EPC, Issued in Connection to EP12839133.1; dated Apr. 25, 2018; 3 pages; Europe. |
Number | Date | Country | |
---|---|---|---|
20180318008 A1 | Nov 2018 | US |
Number | Date | Country | |
---|---|---|---|
61542712 | Oct 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13633967 | Oct 2012 | US |
Child | 15968530 | US |